The economics and cost-effectiveness of critical care medicine
Authors:
- 1 November 1995
- journal article
- review article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 21 (11) , 952-961
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial InfarctionNew England Journal of Medicine, 1995
- Descriptive analysis of critical care units in the United StatesCritical Care Medicine, 1992
- Outcome assessment in cardiovascular cost-benefit studiesAmerican Heart Journal, 1990
- Cost-effectiveness perspectives in coronary heart diseaseAmerican Heart Journal, 1990
- Cost Effectiveness as a Criterion for Medicare CoverageNew England Journal of Medicine, 1989
- Cost Effectiveness of Bone Marrow Transplantation in Acute Nonlymphocytic LeukemiaNew England Journal of Medicine, 1989
- Critical Care Medicine — A New Specialty?New England Journal of Medicine, 1988
- APACHE IICritical Care Medicine, 1985
- Care of Patients with a Low Probability of Acute Myocardial InfarctionNew England Journal of Medicine, 1984
- Identification of Low-Risk Monitor Patients Within a Medical-Surgical Intensive Care UnitMedical Care, 1983